Tokyo court dismisses IHH unit's claims against Daishi Sankyo东京法院驳回IHH旗下公司对大石三共的诉讼请求
KUALA LUMPUR: The Tokyo District Court has dismissed all claims brought by IHH Healthcare Bhd's indirect wholly-owned subsidiary Northern TK Venture Pte Ltd (NTK) against Japanese pharmaceutical company Daiichi Sankyo Company Ltd.
KUALA LUMPUR: The Tokyo District Court has dismissed all claims brought by IHH Healthcare Bhd ’s indirect wholly-owned subsidiary Northern TK Venture Pte Ltd (NTK) against Japanese pharmaceutical company Daiichi Sankyo Company Ltd.
IHH said the court also ordered NTK to bear the costs of the litigation. "NTK respectfully disagrees with the court’s decision and maintains firm confidence in the merits of its position,” it said in a stock exchange filing.
Thank you for your report!
Corporate Malaysia beats the war blues
Robust 2Q keeps corporate growth on track
KLK reassigns Lee Jia Zhang as CEO from Oct 1
吉隆坡：东京地方法院驳回了IHH Healthcare Bhd的间接全资子公司Northern TK Venture Pte Ltd (NTK)对日本制药公司Daiichi Sankyo Company Ltd.提出的所有索赔。
IHH表示，法院还责令NTK承担诉讼费用。该公司在提交给证券交易所的文件中表示：“NTK对法院的裁决表示异议，并对其自身立场的合理性充满信心。”
感谢您的报告！
马来西亚企业战胜了战争阴霾
强劲的第二季度业绩使公司增长保持正轨
雷朋集团任命李嘉章自10月1日起担任首席执行官